Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Huh WK, Joura EA, Giuliano AR, Iversen OE, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet 2017 Sep 5. pii: S0140-6736(17)31821.
PMID: 28886907


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016